Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage

By POLITICO
| June 17, 2023

The blockbuster weight loss drugs' access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...